PHARMA/BIO-TECH UPDATE: BIOGEN IDEC’S NEW HEMOPHILIA DRUG APPROVED IN CANADA
Canada’s approval of Biogen Idec’s long-acting hemophilia B drug may be a foreshadowing into other major countries approving ALPROLIX as…
Canada’s approval of Biogen Idec’s long-acting hemophilia B drug may be a foreshadowing into other major countries approving ALPROLIX as…
Novo Nordisk just announced, via a press release through Fierce Biotech, that their new long acting factor replacement therapy for…
Danielle Simms, the 2014 Miss Broken Arrow Teen contest pageant winner of Oklahoma, knew exactly what her platform for the…
By the year 2020, Bayer Pharmaceuticals hopes to expand its facilities in Germany. According to Fierce Pharma, the company’s hemophilia…
The National Hemophilia Foundation (NHF) will announce their annual award winners on Saturday, September 20, 2014 at their annual meeting held…
The Western Pennsylvania Chapter of the National Hemophilia Foundation announced that they recently raised over $16,000 at their 2nd Annual…
The pharmaceutical market review for hemophilia looks to get competitive on pricing with the releases on some longer acting medications…
People who have encountered an inhibitor in their lifetime know how damaging it can be to the human body. With…
On January 22nd, WeBleed ran a story titled Pharmacist Fraud Case for Hemophilia Ongoing concerning an owner of a specialty pharmacy in…
Have you ever heard of a blood clot? How about a bleeding disorder? Does deep vein thrombosis or Factor V…